Iguratimod

艾拉莫德

Report date: 2022/04/07 10:05:40
NME

Base Information

Drug NameIguratimod
Drug Alias NameColvet艾得辛IremodCareramKolbet +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsGraft vs Host DiseaseSjogren's SyndromeArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaArthritis, Rheumatoid
Original Approved Country/TerritoryMainland China
Original Approved Date2011/08/15
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEisai Co LtdXuzhou Medical University (Xzmu)Hainan Simcere Pharmaceutical Co Ltd
Inactive CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Active IndicationsGraft vs Host DiseaseSjogren's SyndromeArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeM01C
Related LinksWikipediaKEGG